Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical IncfiledCriticalAstute Medical Inc
Priority claimed from NZ604873Aexternal-prioritypatent/NZ604873A/en
Publication of NZ624159ApublicationCriticalpatent/NZ624159A/en
Investigating Or Analysing Biological Materials
(AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Abstract
A method for evaluating renal status in a subject ex vivo, comprises performing one or more assays configured to detect a kidney injury marker on a body fluid sample obtained previously from the subject to provide one or more assay results, the kidney injury marker being Epidermal growth factor; and correlating the assay result(s) to one or more of risk stratification, staging, prognosis, classifying and monitoring of the renal status of the subject. The correlating step comprises assigning a likelihood or risk of future acute renal failure (ARF) suffered by the subject.
NZ624159A2008-11-222009-11-21Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ624159A
(en)